Genes linked to PC risk represented 60% of the findings (BRCA1, BRCA2, and PALB2), and these patients meet current published guidelines recommending PC surveillance with annual imaging beginning at age 50 or 10 years younger than the earliest diagnosis of PC in the family5,6. The gene discussed is BRCA2; the disease is pachyonychia congenita.